Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

GAVISCON PEPPERMINT TABLETS - HSA Drug Approval Details

Approvals/HSA/GAVISCON PEPPERMINT TABLETS

Approved

THERAPEUTIC

GAVISCON PEPPERMINT TABLETS

RECKITT BENCKISER HEALTHCARE (UK) LIMITED (UNITED KINGDOM)🇸🇬 Health Sciences Authority

Approval Date: Apr 14, 2011
Approval ID: 2dc2f00950737bb0
Company: RECKITT BENCKISER HEALTHCARE (UK) LIMITED (UNITED KINGDOM)
Type: Therapeutic

Approval Details

Approval Id: 2dc2f00950737bb0
Drug Name: GAVISCON PEPPERMINT TABLETS
Product Name: GAVISCON PEPPERMINT TABLETS
Approval Number: SIN13947P
Approval Date: 2011-04-14
Registrant: RECKITT BENCKISER (SINGAPORE) PTE LTD
Licence Holder: RECKITT BENCKISER (SINGAPORE) PTE LTD
Drug Type: Therapeutic
Forensic Classification: GENERAL SALE LIST
Dosage Form: TABLET, CHEWABLE
Route Of Administration: ORAL
Atc Code: A02BX13
Atc Item Name: alginic acid
Pharma Manufacturer Name: RECKITT BENCKISER (SINGAPORE) PTE LTD

Active Ingredients

CALCIUM CARBONATE

80MG

SODIUM BICARBONATE

133.5MG

SODIUM ALGINATE

250MG

CALCIUM CARBONATE

80 MG

SODIUM ALGINATE

250 MG

SODIUM BICARBONATE

133.5 MG

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Apr 14, 2011

Approval ID

2dc2f00950737bb0

Type

Therapeutic

Back to HSA Approvals